Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged ≥80 years

European Journal of Clinical Pharmacology

Volumn 59, Issue 4, 2003, Pages 313-319

  Nilsson, Sven E ^a   Johansson, Boo ^a,b   Takkinen, Sanna ^a   Berg, Stig ^a   Zarit, Steven ^c   McClearn, Gerald ^c   Melander, Arne ^d  

^a JÖNKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer; Aspirin; NSAID

Indexed keywords

ACETYLSALICYLIC ACID; DEXTROPROPOXYPHENE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; FEMALE; GENDER; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOW DRUG DOSE; MALE; NEUROPROTECTION; PRIORITY JOURNAL; SWEDEN; TWINS;

ACETAMINOPHEN; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COGNITION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; PROPOXYPHENE; SWEDEN; TWINS;

EID: 0042913340     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-003-0618-y     Document Type: Article

References (27)

1. McGeer PL, Schultzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease. Neurology 47:425-432
2. Stewart WF, Kawas C, Corrada M, Metter EJ (1997) Risk of Alzheimer's disease and duration of NSAID. Neurology 48:46-47
3. Zandi PP, Anthony JC, Hayden KM, Mehta K, Mayer L, Breitner JC (2002) The Cache County study investigators. Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County study. Neurology 59:880-886
4. Broe GA, Grayson DA, Creasey HM, Waite LM, Casey BJ, Bebbett HP, Brooks WS, Halliday GM (2000) Anti-inflammatory drugs protect against Alzheimer's disease at low doses. Arch Neurol 57:1586-1591
5. In't Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MMB, Stricker BHC (2001) Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 345:1515-1521
6. Williams PS, Rands G, Orrel M, Spector A (2000) Aspirin for vascular dementia. Cochrane Database Syst Rev CD001296
7. McClearn GE, Johansson B, Berg S, Pedersen NL, Ahern F, Petrill SA, Plomin R (1997) Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science 276:1560-1563
8. Cederlöf R, Lorich U (1978) (Untitled) in Nance WE, Allen G, Parisi P (eds) Twin research: Part C. Biology and epidemiology. Alan R. Liss, New York, pp 189-195
9. Simmons SF, Johansson B, Zarit SH, Ljungquist B, Plomin R, McClearn GE (1997) Selection bias in samples of older twins. A comparison between octogenarian twins and singletons in Sweden. J Aging Health 9:553-567
10. WHO Collaborating Centre for Drug Statistics Methodology (1996) Guidelines for ATC classification and DDD assignment. WHO, Oslo
11. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders DSM-IV, 4th edn. APA, Washington
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRA work group under the suspicies of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944
13. Román GC, Tatemichi TK, Erkinjuntti T, Cumming JL, Masdeu JC, Garcia JH, Amaducci I, Orgogoza JM, Brun A, Hofman A et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology 43:250-260
14. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
15. Nilsson SE, Johansson B, Berg S, Karlsson D, McClearn GE (2002) A comparison of diagnosis capture from medical records, self-reports, and drug registrations: a study in individuals 80 years and older. Aging Clin Exp Res 14:178-184
16. World Health Organization (1992) ICD-10. International statistical classification of diseases and health problems, 10th revised edn., WHO, Geneva
17. Johansson B, Zarit SH (1995) Prevalence and incidence of dementia in the oldest old: a longitudinal study of a population-based sample of 84-90-year-olds in Sweden. Int J Ger Psychiatry 10:359-366
18. McGeer PL, McGeer EG (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21:195-218
19. McGeer PL (2000) Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease. Drugs Aging 17:1-11
20. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R), 3rd edn., APA, Washington
21. Jonsson C-O, Molander L (1964) Manual of the CVB scales. Psykologi Förlaget, Stockholm
22. Dureman I, Sälde H (1959) Psychometric and experimental-psychological methods for clinical application (in Swedish). Almqvist & Wiksell, Uppsala
23. Wechsler D (1991) Manual for the Wechsler adult intelligence-scale revised. Psychological Corporation, New York
24. Thurstone LL, Thurstone TG (1949) Manual to SRA primary mental abilities. Science Research Associates, Chicago
25. Johansson B (1988) The MIR - memory in reality test. Psykologifö rlaget AB, Stockholm
26. Johansson B, Zarit SH (1991) Dementia and cognitive impairment in the oldest-old: a comparison of two rating methods. Int Psychogeriatr Spring 12:29-38
27. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944